Jamjoom Pharmaceuticals Factory Company SJSC banner

Prices of SAU stocks are not being updated. The latest Jamjoom Pharmaceuticals Factory Company SJSC price on Alpha Spread is from Aug 7, 2024. Financials, forecasts and intrinsic value keep updating.

Intrinsic Value

The intrinsic value of Jamjoom Pharmaceuticals Factory Company SJSC (4015) under the Base Case is 67.8 SAR per share. Compared with the last price of 156 SAR on Aug 7, the stock appears Overvalued by 57% .

The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 11% a year over the next five years, against 13% over the last five, and net margin stays near last year's 31%. If net margin stayed at its five-year average of 25%, the estimate would be about ﷼56.

Do our valuations actually work? See backtest results .

Intrinsic Value
﷼67.8
Overvaluation 57%
Intrinsic Value
Price ﷼156

We don’t have enough historical valuation data to make this comparison.

Monitor Jamjoom Pharmaceuticals Factory Company SJSC
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ﷼54.24
Get notified when the price drops into your buy zone
Current Price ﷼156
Intrinsic Value ﷼67.8
Margin of Safety 20% ﷼54.24
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Jamjoom Pharmaceuticals Factory Company SJSC

Fundamental Analysis

What Jamjoom Pharmaceuticals Factory Company SJSC Does

Pharmaceuticals Health Care

Jamjoom Pharmaceuticals Factory Company SJSC, nestled in the heart of Saudi Arabia, has emerged as a formidable player in the Middle East's pharmaceutical landscape. Founded in 1994, the company was borne out of a vision to cater to the growing healthcare demands of the region, leveraging both high-tech manufacturing and rigorous scientific research. Initially focused on generic medications, Jamjoom Pharmaceuticals has since expanded its portfolio to include a diverse range of products from ophthalmology to dermatology.

Headquarters
Saudi Arabia SA
Employees
1 130
IPO date
Jun 20, 2023
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Jamjoom Pharmaceuticals Factory Company SJSC

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Jamjoom Pharmaceuticals Factory Company SJSC stock?

The intrinsic value for Jamjoom Pharmaceuticals Factory Company SJSC (4015) under the Base Case is 67.8 SAR.

Is Jamjoom Pharmaceuticals Factory Company SJSC stock undervalued or overvalued?

Compared with the last price of 156 SAR on Aug 7, the stock appears Overvalued by 57% .

Back to Top